PRAME expression and clinical outcome of breast cancer

per Epping, M T, Hart, A A M, Glas, A M, Krijgsman, O, Bernards, R
Publicat 2008

Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients

per Weigelt, B, Bosma, A J, Hart, A A M, Rodenhuis, S, van 't Veer, L J
Publicat 2003

The influence of tamoxifen treatment on the oestrogen receptor in metachronous contralateral breast cancer

per Kaas, R, Peterse, J L, Hart, A A M, Voogd, A C, Rutgers, E J T, van Leeuwen, F E
Publicat 2003

Effects of patient selection on the applicability of results from a randomised clinical trial (EORTC 10853) investigating breast-conserving therapy for DCIS

per Bijker, N, Peterse, J L, Fentiman, I S, Julien, J-P, Hart, A A M, Avril, A, Cataliotti, L, Rutgers, E J T
Publicat 2002

Cisplatin-DNA adduct formation in patients treated with cisplatin-based chemoradiation: lack of correlation between normal tissues and primary tumor

per Hoebers, F. J. P., Pluim, D., Hart, A. A. M., Verheij, M., Balm, A. J. M., Fons, G., Rasch, C. R. N., Schellens, J. H. M., Stalpers, L. J. A., Bartelink, H., Begg, A. C.
Publicat 2007